Social media is awash with rumours about dermal fillers becoming a prescription only medicine (POM).

Even the JCCP has issued a new statement on the subject – once again calling for this to happen.

The MHRA (Medicines and Healthcare Products Regulatory Agency) previously has confirmed that it has no plans to make dermal fillers prescription only. And it is the body that makes the decision.

Quite simply they state – quite correctly – that fillers are not a medicine!

The JCCP says that it understands that any future requirement for fillers to be prescription only will impact some practitioners, however, the JCCP’s stated priority is public safety and protection.

They claim that the decision to require prescription status: “…does not relate to the intent, medical or otherwise, of the treatment, but rather to the balance of risk.”

The JCCP also claims (without substantiating this with evidence) that: “The risks attached to dermal filler treatments are documented and well known, and complications require medical intervention for safe, legal and effective resolution.”

And also: “It should be noted that the assessment of any member of the public who elects to receive a dermal filler treatment is, in significant part, medically related. There are a myriad of medical cautions and relative contraindications associated with the decision to proceed to treatment that cannot be adequately covered in the absence of clinical oversight.”

Recently, The All-Party Parliamentary Group on Beauty, Aesthetics and Wellbeing also called for this change in the law in their major report.

In 2018 the MHRA said it had no plans to make dermal fillers a POM but today The ACPB has asked if that is still the case given the recent wave of calls for change.